JP Morgan Chase
SRTA

JP Morgan Chase’s Strata Critical Medical Inc SRTA Stock Holding History

JP Morgan Chase’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.3M Sell
320,234
-26,928
-8% -$130K ﹤0.01% 4424
2025
Q4 		$1.67M Buy
347,162
+88,023
+34% +$426K ﹤0.01% 4227
2025
Q3 		$1.31M Buy
259,139
+63,139
+32% +$279K ﹤0.01% 4389
2025
Q2 		$790K Sell
196,000
-398,227
-67% -$1.3M ﹤0.01% 4523
2025
Q1 		$1.62M Sell
594,227
-101,309
-15% -$363K ﹤0.01% 4012
2024
Q4 		$2.96M Sell
695,536
-25,543
-4% -$97.2K ﹤0.01% 3851
2024
Q3 		$2.12M Sell
721,079
-195,163
-21% -$621K ﹤0.01% 3965
2024
Q2 		$3.19M Buy
916,242
+37,567
+4% +$125K ﹤0.01% 3395
2024
Q1 		$2.5M Buy
878,675
+164,990
+23% +$509K ﹤0.01% 3668
2023
Q4 		$2.52M Buy
713,685
+106,203
+17% +$305K ﹤0.01% 3659
2023
Q3 		$1.57M Buy
607,482
+561,964
+1,235% +$1.97M ﹤0.01% 3734
2023
Q2 		$179K Buy
45,518
+1,945
+4% +$6.17K ﹤0.01% 5142
2023
Q1 		$147K Buy
43,573
+10,326
+31% +$42.1K ﹤0.01% 5247
2022
Q4 		$119K Sell
33,247
-16,912
-34% -$72.3K ﹤0.01% 5284
2022
Q3 		$203K Sell
50,159
-26,916
-35% -$138K ﹤0.01% 4948
2022
Q2 		$344K Buy
77,075
+44,683
+138% +$322K ﹤0.01% 4771
2022
Q1 		$275K Buy
+32,392
New +$228K ﹤0.01% 5014
2021
Q4 		– Sell
-31
Closed -$295 – 6644
2021
Q3 		$0 Buy
+31
New +$271 ﹤0.01% 6481
2020
Q4 		– Sell
-298,314
Closed -$3.02M – 5634
2020
Q3 		$3.02M Buy
298,314
+73,349
+33% +$741K ﹤0.01% 2954
2020
Q2 		$2.24M Hold
224,965
– – ﹤0.01% 3032
2020
Q1 		$2.17M Buy
+224,965
New +$2.23M ﹤0.01% 2903

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $221M AUM
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase's SRTA Position: Q1 2026 in Review

JP Morgan Chase reduced its Strata Critical Medical Inc (SRTA) stake by 7.8% in Q1 2026, selling an estimated $130K and leaving 320,234 shares worth $1.3M. The position accounts for ﹤0.01% of the portfolio, ranked #4424.

JP Morgan Chase first reported a position in SRTA in Q1 2020 and has held it in 21 quarters since. The position peaked at $3.19M in Q2 2024. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • JP Morgan Chase held 320,234 shares of Strata Critical Medical Inc worth $1.3M as of Q1 2026.
  • JP Morgan Chase sold 26,928 Strata Critical Medical Inc shares in Q1 2026, an estimated $130K.
  • Strata Critical Medical Inc made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #4424 holding.
  • JP Morgan Chase first reported a position in Strata Critical Medical Inc in Q1 2020 and has held it in 21 quarters since.
  • JP Morgan Chase's Strata Critical Medical Inc position peaked at $3.19M in Q2 2024.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.